C3RY Profitability Analysis: Margins, Return on Capital, Free Cash Flow, and More - Cherry SE

Watchlist Manager

Watchlist

Price: 1 EUR -28.57% Market Closed

Market Cap: €23.5m

	Cherry SE F:C3RY	DE
U	United Therapeutics Corp XBER:UTH	US
W	Waste Connections Inc F:UI51	CA
A	Avex Inc F:AX8	JP
T	Takeda Pharmaceutical Co Ltd OTC:TKPHF	JP
C	Canon Marketing Japan Inc XMUN:CNJ	JP
M	Muenchener Rueckversicherungs Gesellschaft in Muenchen AG OTC:MURGY	DE
T	Telefonaktiebolaget LM Ericsson SWB:ERCA	SE
M	Materialise NV SWB:06MA	BE
	Materialise NV NASDAQ:MTLS	BE
	Redcare Pharmacy NV F:RDC	NL

Profitability Summary

Cherry SE's profitability score is Hidden . We take all the information about a company's profitability, such as its margins, capital efficiency, free cash flow generating ability, and more, and consolidate it into one single number: the profitability score. The higher the profitability score, the more profitable the company is.

Low Gross Margin

Sustainable 3Y Average Gross Margin

13%

Declining Gross Margin

27% > 9%

Negative Operating Margin

-56%

Negative 3Y Average Operating Margin

-63%

Declining Operating Margin

-33% > -56%

Negative Net Margin

-54%

Negative 3Y Average Net Margin

-67%

Declining Net Margin

-31% > -54%

Negative Free Cash Flow Margin

-8%

Negative 3Y Average Free Cash Flow Margin

-15%

Free Cash Flow Margin is Increasing

-24% > -8%

Negative ROE

-63%

Negative 3Y Average ROE

Negative 3Y Average ROIC

-35%

Declining ROIC

-13% > -36%

View All Checks

We take all the information about a company's profitability, such as its margins, capital efficiency, free cash flow generating ability, and more, and consolidate it into one single number: the profitability score. The higher the profitability score, the more profitable the company is.

Low Gross Margin

Sustainable 3Y Average Gross Margin

13%

Declining Gross Margin

27% > 9%

Negative Operating Margin

-56%

Negative 3Y Average Operating Margin

-63%

Declining Operating Margin

-33% > -56%

Negative Net Margin